COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines.

Wohl, David A; Espinueva, Aprille A; Dau, Lauren; Wang, Chen-Yu; Lachmann, Alexandra; Bam, Rujuta A; Rawal, Aaditya; Chappell-Smith, Kerris; Rockstroh, Juergen K

Wohl, David A; Espinueva, Aprille A; Dau, Lauren; Wang, Chen-Yu; Lachmann, Alexandra; Bam, Rujuta A; Rawal, Aaditya; Chappell-Smith, Kerris; Rockstroh, Juergen K.

Afiliación

Wohl DA; Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Espinueva AA; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Dau L; Gilead Sciences Inc., Foster City, CA, USA.
Wang CY; Gilead Sciences Inc., Foster City, CA, USA.
Lachmann A; Gilead Sciences Inc., Foster City, CA, USA.
Bam RA; Gilead Sciences Inc., Foster City, CA, USA.
Rawal A; Gilead Sciences Inc., Foster City, CA, USA.
Chappell-Smith K; Costello Medical, Boston, MA, USA.
Rockstroh JK; Costello Medical, Cambridge, UK.

ERJ Open Res ; 8(4)2022 Oct.

Article en En | MEDLINE | ID: mdl-36411792

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: ERJ Open Res Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google